Abstract
The Xiaoke Pill containing Chinese herb extracts and Glibenclamide, is used in therapy for type 2 diabetes mellitus (T2DM), and is effective in reducing the risk of hypoglycemia and improving diabetes symptoms compared with Glibenclamide. We describe a quantitative proteomics project to measure the T2DM serum proteome response to the Xiaoke Pill and Glibenclamide. Based on a recently conducted 48-week clinical trial comparing the safety and efficacy of Glibenclamide (n = 400) and Xiaoke Pill (n = 400), after matching for age, sex, BMI, drug dose and whether hypoglycemia occurred, 32 patients were selected for the serum based proteomic analysis and divided into four groups (with/without hypoglycemia treated with Xiaoke Pill or Glibenclamide, n = 8 for each group). We screened the differential serum proteins related to treatments and the onset of hypoglycemia using the iTRAQ labeling quantitative proteomics technique. Baseline and follow-up samples were used. The quantitative proteomics experiments demonstrated that 25 and 21 proteins differed upon treatment with the Xiaoke Pill in patients without and with hypoglycemia, respectively, while 24 and 25 proteins differed upon treatment with Glibenclamide in patients without and with...Continue Reading
References
Jan 30, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·R C RobertsA K McKenzie
May 12, 2000·Journal of Clinical Pharmacology·J T Cheng
Oct 26, 2001·JAMA : the Journal of the American Medical Association·S YusufUNKNOWN HOPE Study Investigators
Apr 13, 2004·Journal of Hypertension·Anders NiklasonUNKNOWN Captopril Prevention Project Study Group
Jun 10, 2004·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Enrique Z FismanSolomon Behar
Aug 1, 2006·Diabetes Research and Clinical Practice·Mohammad HashemiSaeid Ghavami
Sep 5, 2006·Journal of Diabetes and Its Complications·Sabine E HoferKim C Donaghue
Aug 2, 2008·The Diabetes Educator·Emily Wang, Judith Wylie-Rosett
Jan 20, 2009·Journal of Lipid Research·Philip W ConnellyAnthony J G Hanley
Nov 6, 2009·American Journal of Physiology. Cell Physiology·Kwan Yi ChuPo Sing Leung
Dec 24, 2010·PloS One·Ramasamy SaminathanBalram Chowbay
Sep 20, 2011·Clinical Chemistry·Claudia CangemiLars Melholt Rasmussen
Oct 8, 2011·Obesity·Nishan S KalupahanaNaima Moustaid-Moussa
Nov 1, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·N S Kalupahana, N Moustaid-Moussa
Jan 9, 2013·Cardiovascular Diabetology·Alexandra ScholzeLars M Rasmussen
Mar 6, 2013·PloS One·Linong JiUNKNOWN Evidence-Based Medical Research of Xiaoke Pill Study Group
Apr 3, 2013·Journal of Proteome Research·Shenyan ZhangSiqi Liu
Aug 22, 2013·Methods in Molecular Biology·Theodoros A KoutroukidesKathryn S Lilley
Sep 24, 2013·BioMed Research International·Mitsuaki YanagidaIwao Sekigawa
Dec 26, 2015·Obesity·Monique J LeMieuxNaïma Moustaïd-Moussa
Citations
Aug 23, 2019·Current Drug Targets·Jianbo FuFeng Zhu
Jan 15, 2019·Chinese Medicine·Yi-Yao YangJian-Li Gao
Oct 7, 2020·Medicine·Jie LiYunsheng Xu